Millennium Management LLC 13D and 13G filings for Viking Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-12 4:26 pm Sale | 2023-12-31 | 13G | Viking Therapeutics, Inc. VKTX | Millennium Management LLC | 403,556 0.400% | -4,425,644 (-91.64%) | Filing |
| 2023-01-03 4:51 pm Purchase | 2022-12-23 | 13G | Viking Therapeutics, Inc. VKTX | Millennium Management LLC | 4,829,200 6.300% | 4,829,200 (New Position) | Filing |